Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Disparities in the reporting of distribution of health care
Afshin Parsikia, Jorge Ortiz – 17 May 2014
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation
Jackrapong Bruminhent, Raymund R. Razonable – 17 May 2014 – Cytomegalovirus (CMV) infection has been associated with poor outcomes after liver transplantation. Whether it is safe to perform transplantation for patients with active CMV viremia is not known. Here we report the outcomes of 6 patients with CMV viremia immediately before or at the time of liver transplantation.
HepG2 cells mount an effective antiviral interferon‐lambda based innate immune response to hepatitis C virus infection
Benjamin Israelow, Christopher M. Narbus, Marion Sourisseau, Matthew J. Evans – 16 May 2014 – Hepatitis C virus (HCV) exposure leads to persistent life‐long infections characterized by chronic inflammation often developing into cirrhosis and hepatocellular carcinoma. The mechanism by which HCV remains in the liver while inducing an inflammatory and antiviral response remains unclear.
Cholangiocarcinoma development: The resurgence of bile acids
Luca Maroni, Gianfranco Alpini, Marco Marzioni – 15 May 2014
Hepatitis B virus: The “metabolovirus” highjacks cholesterol and bile acid metabolism
Andreas Geier – 15 May 2014
Treating thrombosis in cirrhosis patients with new oral agents: Ready or not?
Nicolas M. Intagliata, Hillary Maitland, Patrick G. Northup, Stephen H. Caldwell – 15 May 2014
Valuing cure: Bridging cost‐effectiveness and coverage decisions for hepatitis C therapy
Mai T. Pho, Benjamin P. Linas – 14 May 2014
MicroRNA‐331‐3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine‐rich repeat protein phosphatase
Rui‐Min Chang, Hao Yang, Feng Fang, Jiang‐Feng Xu, Lian‐Yue Yang – 14 May 2014 – Hepatocellular carcinoma (HCC) is a highly invasive tumor with frequent intrahepatic or pulmonary metastasis, which is the main reason for high recurrence and poor survival of HCC after liver resection. However, the mechanisms for metastasis remain incompletely clear. Given that microRNAs (miRNAs) are implicated in HCC progression, we explored a potential role of miRNAs in metastasis by performing miRNA expression profiling in three subtypes of HCC with different metastatic potentials.